{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T04:01:21Z","timestamp":1784779281534,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00210-026-05392-9","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T03:31:41Z","timestamp":1777347101000},"page":"15433-15449","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mechanistic and AI-assisted evaluation of paclitaxel-loaded HSPC liposomes for targeted breast cancer therapy"],"prefix":"10.1007","volume":"399","author":[{"given":"Vikram Subraya","family":"Shenoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramkumar","family":"Pillappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrinivas R.","family":"Zanwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogesh H.","family":"Bhosale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devendra L.","family":"Bhuyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukesh Chandra","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil Tulshiram","family":"Hajare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"issue":"4","key":"5392_CR1","doi-asserted-by":"publisher","DOI":"10.36922\/arnm.4373","volume":"2","author":"R Basu","year":"2024","unstructured":"Basu R, Schwartz JG, Phillips WT (2024) Applications of radionuclide-carrying liposomes for diagnosis and treatment of cancer. Adv Radiother Nucl Med 2(4):4373. https:\/\/doi.org\/10.36922\/arnm.4373","journal-title":"Adv Radiother Nucl Med"},{"issue":"11","key":"5392_CR2","first-page":"1843","volume":"2","author":"D Belotti","year":"1996","unstructured":"Belotti D, Vergani V, Drudis T, Borsotti P, Pitelli MR, Viale G et al (1996) The microtubule-affecting drug paclitaxel has antiangiogenic activity. Clin Cancer Res 2(11):1843\u20131849","journal-title":"Clin Cancer Res"},{"key":"5392_CR3","first-page":"169","volume":"2460","author":"ML Berre","year":"2022","unstructured":"Berre ML, Gerlach JQ, Dziemba\u0142a I, Kilcoyne M (2022) Calculating half maximal inhibitory concentration (IC50) values from glycomics microarray data using GraphPad Prism. Methods Mol Biol 2460:169\u2013185","journal-title":"Methods Mol Biol"},{"issue":"2","key":"5392_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics9020012","volume":"9","author":"U Bulbake","year":"2017","unstructured":"Bulbake U, Doppalapudi S, Kommineni N, Khan W (2017) Liposomal formulations in clinical use: An updated review. Pharmaceutics 9(2):12","journal-title":"Pharmaceutics"},{"issue":"3","key":"5392_CR5","volume":"16","author":"M Chountoulesi","year":"2023","unstructured":"Chountoulesi M, Selianitis D, Pispas S, Pippa N (2023) Recent advances on PEO-PCL block and graft copolymers as nanocarriers for drug delivery applications. Materials (Basel) 16(3):1081","journal-title":"Materials (Basel)"},{"issue":"1-2","key":"5392_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0168-3659(99)00166-2","volume":"63","author":"P Crosasso","year":"2000","unstructured":"Crosasso P, Ceruti M, Brusa P, Arpicco S, Dosio F, Cattel L (2000) Preparation and properties of sterically stabilized paclitaxel containing liposomes. J Control Release 63(1\u20132):19\u201330","journal-title":"J Control Release"},{"issue":"4","key":"5392_CR7","first-page":"3346","volume":"235","author":"Q Ding","year":"2020","unstructured":"Ding Q, Zhang W, Cheng C, Mo F, Chen L, Peng G et al (2020) Dioscin inhibits the growth of human osteosarcoma by inducing G2\/M\u2010phase arrest, apoptosis, and GSDME\u2010dependent cell death in vitro and in vivo. J Cell Physiol 235(4):3346\u20133359","journal-title":"J Cell Physiol"},{"issue":"3","key":"5392_CR8","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ymeth.2007.11.006","volume":"44","author":"F Doonan","year":"2008","unstructured":"Doonan F, Cotter TG (2008) Morphological assessment of apoptosis. Methods 44(3):200\u2013204","journal-title":"Methods"},{"issue":"4","key":"5392_CR9","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/S0031-6997(24)01426-1","volume":"51","author":"DC Drummond","year":"1999","unstructured":"Drummond DC, Meyer O, Hong K, Kirpotin DB, Papahadjopoulos D (1999) Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol Rev 51(4):691\u2013743","journal-title":"Pharmacol Rev"},{"issue":"4","key":"5392_CR10","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s12291-013-0296-1","volume":"28","author":"MKM Esfahani","year":"2013","unstructured":"Esfahani MKM, Alavi SE, Movahedi F, Alavi F, Akbarzadeh A (2013) Cytotoxicity of liposomal paclitaxel in breast cancer cell line MCF-7. Indian J Clin Biochem 28(4):358\u2013362","journal-title":"Indian J Clin Biochem"},{"issue":"8","key":"5392_CR11","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.4314\/tjpr.v13i8.1","volume":"13","author":"MKM Esfahani","year":"2014","unstructured":"Esfahani MKM, Alavi SE, Akbarzadeh A, Ghassemi S, Saffari Z, Farahnak M et al (2014) Pegylation of nanoliposomal paclitaxel enhances its efficacy in breast cancer. Trop J Pharm Res 13(8):1195\u20131200","journal-title":"Trop J Pharm Res"},{"issue":"12","key":"5392_CR12","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1139\/Y10-097","volume":"88","author":"M Heney","year":"2010","unstructured":"Heney M, Alipour M, Vergidis D, Omri A, Mugabe C, Th\u2019ng J et al (2010) The effectiveness of liposomal paclitaxel against MCF-7 breast cancer cells. Can J Physiol Pharmacol 88(12):1172\u20131180","journal-title":"Can J Physiol Pharmacol"},{"issue":"1","key":"5392_CR13","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1080\/21691401.2018.1561457","volume":"47","author":"AK Jain","year":"2019","unstructured":"Jain AK, Thareja S (2019) In vitro and in vivo characterization of pharmaceutical nanocarriers used for drug delivery. Artif Cells Nanomed Biotechnol 47(1):524\u2013539","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"17","key":"5392_CR14","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.2217\/nnm-2022-0069","volume":"17","author":"D Kapoor","year":"2022","unstructured":"Kapoor D, Sharma S, Verma K, Bisht A, Sharma M, Singhai NJ, Raval N, Maheshwari R (2022) Quality-by-design-based engineered liposomal nanomedicines to treat cancer: an in-depth analysis. Nanomedicine 17(17):1173\u20131189","journal-title":"Nanomedicine"},{"key":"5392_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/9783527841165.ch3","volume":"23","author":"DU Kapoor","year":"2023","unstructured":"Kapoor DU, Goyal R, Kukkar RR, Gautam RK (2023) Recent advancement of nanotherapeutics to treat breast cancer. Drug and Therapy Development for Triple Negative Breast Cancer 23:65\u201383","journal-title":"Drug and Therapy Development for Triple Negative Breast Cancer"},{"issue":"5","key":"5392_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/star.202400251","volume":"77","author":"DU Kapoor","year":"2025","unstructured":"Kapoor DU, Patel G, Prajapati BG (2025) Revolutionizing cancer treatment: the role of starch\u2010based nanoparticles in targeted therapy. Starch St\u00e4rke 77(5):e202400251","journal-title":"Starch St\u00e4rke"},{"issue":"13","key":"5392_CR17","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1096\/fasebj.9.13.7557017","volume":"9","author":"G Kroemer","year":"1995","unstructured":"Kroemer G, Petit P, Zamzami N, Vayssi\u00e8re JL, Mignotte B (1995) The biochemistry of programmed cell death. FASEB J 9(13):1277\u20131287","journal-title":"FASEB J"},{"issue":"35","key":"5392_CR18","first-page":"16119","volume":"144","author":"L Lei","year":"2022","unstructured":"Lei L, Yang F, Meng X, Xu L, Liang P, Ma Y et al (2022) Noninvasive imaging of tumor glycolysis and chemotherapeutic resistance via de novo design of molecular afterglow scaffold. J Am Chem Soc 144(35):16119\u201316128","journal-title":"J Am Chem Soc"},{"issue":"1","key":"5392_CR19","first-page":"15","volume":"2","author":"F Movahedi","year":"2013","unstructured":"Movahedi F, Esfahani MKM, Alavi SE, Akbarzadeh A (2013) Cytotoxicity assessment of nanoliposomal paclitaxel and nanoliposomal hydroxyurea in MCF-7 cells. J Pharm Health Sci 2(1):15\u201317","journal-title":"J Pharm Health Sci"},{"key":"5392_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.985363","volume":"12","author":"S Qian","year":"2022","unstructured":"Qian S, Wei Z, Yang W, Huang J, Wang J (2022) The role of BCL-2 family proteins in regulating apoptosis and cancer therapy. Front Oncol 12:986879","journal-title":"Front Oncol"},{"issue":"1","key":"5392_CR21","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1186\/s12967-022-03641-y","volume":"20","author":"L Ren","year":"2022","unstructured":"Ren L, Yang Y, Li W, Zheng X, Liu J, Li S et al (2022) CDK1 serves as a therapeutic target of adrenocortical carcinoma via regulating epithelial\u2013mesenchymal transition, G2\/M phase transition, and PANoptosis. J Transl Med 20(1):369","journal-title":"J Transl Med"},{"issue":"11","key":"5392_CR22","volume":"10","author":"G Renga","year":"2022","unstructured":"Renga G, Nunzi E, Pariano M, Puccetti M, Bellet M, Pieraccini G et al (2022) Optimizing therapeutic outcomes of immune checkpoint blockade by a microbial tryptophan metabolite. J Immunother Cancer 10(11):e005589","journal-title":"J Immunother Cancer"},{"issue":"1","key":"5392_CR23","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13578-022-00915-2","volume":"12","author":"M Riba","year":"2022","unstructured":"Riba M, Campo-Sabariz J, Tena I, Molina-Porcel L, Ximelis T, Calvo M et al (2022) Wasteosomes (Corpora amylacea) of human brain can be phagocytosed and digested by macrophages. Cell Biosci 12(1):130","journal-title":"Cell Biosci"},{"issue":"6","key":"5392_CR24","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1023\/A:1018994111594","volume":"11","author":"A Sharma","year":"1994","unstructured":"Sharma A, Straubinger RM (1994) Novel Taxol formulations: preparation and characterization of Taxol-containing liposomes. Pharm Res 11(6):889\u2013896","journal-title":"Pharm Res"},{"issue":"1","key":"5392_CR25","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/0304-3835(96)04380-7","volume":"107","author":"A Sharma","year":"1996","unstructured":"Sharma A, Sharma US, Straubinger RM (1996) Paclitaxel liposomes for intracavitary therapy of intraperitoneal P388 leukemia. Cancer Lett 107(1):265\u2013272","journal-title":"Cancer Lett"},{"issue":"1","key":"5392_CR26","first-page":"1","volume":"6","author":"VS Shenoy","year":"2011","unstructured":"Shenoy VS, Gude RP, Murthy RSR (2011) Investigations on paclitaxel loaded HSPC based conventional and PEGylated liposomes: in vitro release and cytotoxic studies. Asian J Pharm Sci 6(1):1\u20137","journal-title":"Asian J Pharm Sci"},{"key":"5392_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2022.892306","volume":"9","author":"Y Shilo-Benjamini","year":"2022","unstructured":"Shilo-Benjamini Y, Cern A, Zilbersheid D, Hod A, Lavy E, Barasch D et al (2022) A case report of subcutaneously injected liposomal cannabidiol formulation used as a compassion therapy for pain management in a dog. Front Vet Sci 9:921788","journal-title":"Front Vet Sci"},{"key":"5392_CR28","volume-title":"Taxol\u00ae: science and applications","author":"M Suffness","year":"1996","unstructured":"Suffness M (1996) Taxol\u00ae: science and applications. CRC Press, Boca Raton"},{"issue":"3","key":"5392_CR29","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"issue":"382","key":"5392_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113656","volume":"10","author":"KH Wong","year":"2025","unstructured":"Wong KH, Wang Y, Wang X, Yin Y, Feng K, Chen M (2025) Unsaturated fatty acid-doped liposomes deliver piperine to deactivate defensive mechanism for ferroptosis in cancer therapy. J Control Release 10(382):113656","journal-title":"J Control Release"},{"issue":"1","key":"5392_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-022-00666-3","volume":"27","author":"M Xia","year":"2022","unstructured":"Xia M, Zhao F, Zhang Y, Zheng Z, Zhou Y, Liu T (2022) Identification of diagnostic markers and immune cell infiltration characteristics in antineutrophil cytoplasmic antibody-associated vasculitis by weighted gene co-expression network analysis. Eur J Med Res 27(1):339","journal-title":"Eur J Med Res"},{"issue":"1","key":"5392_CR32","volume":"8","author":"NN Xie","year":"2023","unstructured":"Xie NN, Shen G, Gao W, Huang Z, Huang C, Fu L (2023) Neoantigens: promising targets for cancer therapy. Signal Transduct Target Ther 8(1):167","journal-title":"Signal Transduct Target Ther"},{"key":"5392_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/exp.20240123","author":"P Xue","year":"2025","unstructured":"Xue P, Bai T, Zhuang H, All AH, Yan S, Zeng X (2025) Cholesterol metabolism regulated nanoliposome ameliorates chemo\/photothermal therapy reversing CD8+ T cell exhaustion. Exploration. https:\/\/doi.org\/10.1002\/exp.20240123","journal-title":"Exploration"},{"issue":"5","key":"5392_CR34","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1080\/10717544.2018.1455763","volume":"14","author":"T Yang","year":"2007","unstructured":"Yang T, Cui F-D, Choi M-K, Lin H, Chung S-J, Shim C-K, Kim DD (2007) Liposome formulation of paclitaxel with enhanced solubility and stability. Drug Deliv 14(5):301\u2013308. https:\/\/doi.org\/10.1080\/10717544.2018.1455763","journal-title":"Drug Deliv"},{"issue":"1","key":"5392_CR35","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ejpb.2004.06.009","volume":"59","author":"AJ Zhang","year":"2005","unstructured":"Zhang AJ, Anyarambhatla G, Ma L, Ugwu S, Xuan T, Sardone T et al (2005) Development and characterization of a novel Cremophor\u00ae EL free liposome-based paclitaxel (LEP-ETU) formulation. Eur J Pharm Biopharm 59(1):177\u2013187","journal-title":"Eur J Pharm Biopharm"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05392-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05392-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05392-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T03:05:14Z","timestamp":1784775914000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05392-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["5392"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05392-9","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"11 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Institutional R & D Ethics Committee (IMUMCEP-28\/2023).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}